Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Karch

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2013
Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrierMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profilesRobert Sauermann, Rudolf Karch, Herbert Langenberger, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
European Journal of Clinical Pharmacology|March 24, 2012
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pusRobert Sauermann, Thomas Feurstein, Rudolf Karch, et al.
Nuclear Medicine and Biology|June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in ratsJulia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PETClaudia C Wagner, Martin Bauer, Rudolf Karch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PETJens P Bankstahl, Claudia Kuntner, Aiman Abrahim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humansOliver Langer, Rudolf Karch, Ulrich Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2007
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patientsAiman Abrahim, Gert Luurtsema, Martin Bauer, et al.
Clinical Pharmacokinetics|December 15, 2010
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamilClaudia C Wagner, Marie Simpson, Markus Zeitlinger, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2013
Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrierMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profilesRobert Sauermann, Rudolf Karch, Herbert Langenberger, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
European Journal of Clinical Pharmacology|March 24, 2012
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pusRobert Sauermann, Thomas Feurstein, Rudolf Karch, et al.
Nuclear Medicine and Biology|June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in ratsJulia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PETClaudia C Wagner, Martin Bauer, Rudolf Karch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PETJens P Bankstahl, Claudia Kuntner, Aiman Abrahim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humansOliver Langer, Rudolf Karch, Ulrich Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2007
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patientsAiman Abrahim, Gert Luurtsema, Martin Bauer, et al.
Clinical Pharmacokinetics|December 15, 2010
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamilClaudia C Wagner, Marie Simpson, Markus Zeitlinger, et al.
Pageof 5